(Q46599209)

English

Urothelial carcinogenesis in the urinary bladder of rats treated with naveglitazar, a gamma-dominant PPAR alpha/gamma agonist: lack of evidence for urolithiasis as an inciting event

scientific article published in February 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18474944

Urothelial carcinogenesis in the urinary bladder of rats treated with naveglitazar, a gamma-dominant PPAR alpha/gamma agonist: lack of evidence for urolithiasis as an inciting event (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18474944

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Gerald G Long

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18474944

Vincent L Reynolds

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18474944

Alric Lopez-Martinez

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18474944

Thomas E Ryan

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18474944

Sandy L White

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18474944

Sandra R Eldridge

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18474944

language of work or name

0 references

publication date

1 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18474944

Toxicologic Pathology

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18474944

36

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18474944

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18474944

218-231

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18474944

The mechanisms of action of PPARs

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

Effects of stones and other physical factors on the induction of rodent bladder cancer

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

Effects of PPARgamma and combined agonists on the urinary tract of rats and other species

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

Mitogenic effects of propoxur on male rat bladder urothelium.

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

Urinary tract calculi and thresholds in carcinogenesis.

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

Investigations of rodent urinary bladder carcinogens: collection, processing, and evaluation of urine and bladders

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: Evidence for urolithiasis as the inciting event in the mode of action.

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

Biomarkers for early effects of carcinogenic dual-acting PPAR agonists in rat urinary bladder urothelium in vivo

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

Measurement of chemically induced cell proliferation in rodent liver and kidney: a comparison of 5-bromo-2'-deoxyuridine and [3H]thymidine administered by injection or osmotic pump

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

Dependence of peroxisome proliferator-activated receptor ligand-induced mitogen-activated protein kinase signaling on epidermal growth factor receptor transactivation

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

Neoplastic and nonneoplastic lesions in aging F344 rats

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

Cytokeratin 20 expression by non-invasive transitional cell carcinomas: potential for distinguishing recurrent from non-recurrent disease.

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

Expression of cytokeratin 20 redefines urothelial papillomas of the bladder.

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

PPARgamma ligands suppress proliferation of human urothelial basal cells in vitro

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

Overall false positive rates in tests for linear trend in tumor incidence in animal carcinogenicity studies of new drugs.

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

Growth factors and bladder cancer: clinical implications of the interactions between growth factors and their urothelial receptors

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

Epidermal growth factor--interactions with normal and malignant urothelium: in vivo and in situ studies

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

Unit length as the denominator for quantitation of cell proliferation in nasal epithelia

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

Generalized cellular hypertrophy is induced by a dual-acting PPAR agonist in rat urinary bladder urothelium in vivo

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

Uroplakins and cytokeratins in the regenerating rat urothelium after sodium saccharin treatment

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

Activators of the nuclear receptor PPARgamma enhance colon polyp formation

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

Urothelial differentiation in chronically urine-deprived bladders of patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

Activation of peroxisome proliferator-activated receptor-gamma reverses squamous metaplasia and induces transitional differentiation in normal human urothelial cells

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

What determines differentiation of urothelial umbrella cells?

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

Expression of peroxisome proliferator-activated receptors (PPARs) in human urinary bladder carcinoma and growth inhibition by its agonists.

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

Differential Regulation of Vascular Endothelial Growth Factor Expression by Peroxisome Proliferator-activated Receptors in Bladder Cancer Cells

1 reference

https://api.crossref.org/works/10.1177%2F0192623307311757

21 January 2018

Identifiers

10.1177/0192623307311757

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18474944

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18474944

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46599209&oldid=2121369983"